{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T12:15:31Z","timestamp":1753359331646},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,7,19]],"date-time":"2015-07-19T00:00:00Z","timestamp":1437264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00115-014-4148-x","type":"journal-article","created":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T13:05:41Z","timestamp":1437138341000},"page":"1097-1110","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pharmakotherapie von psychiatrischen Akut- und Notfallsituationen"],"prefix":"10.1007","volume":"86","author":[{"given":"T.","family":"Messer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.-G.","family":"Pajonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,19]]},"reference":[{"key":"4148_CR1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/bmj.327.7417.708","volume":"327","author":"TREC","year":"2003","unstructured":"TREC Collaborative Group (2003) Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine. BMJ 327:708\u2013713","journal-title":"BMJ"},{"key":"4148_CR2","first-page":"1139","volume":"81","author":"Ables","year":"2010","unstructured":"Ables AZ, Nagubilli R (2010) Prevention, recognition, and management of serotonin syndrome. Am Fam Physician 81:1139\u20131142","journal-title":"Am Fam Physician"},{"key":"4148_CR3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.185.1.63","volume":"185","author":"Alexander","year":"2004","unstructured":"Alexander J, Tharyan P, Adams C et al (2004) Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine. Br J Psychiatry 185:63\u201369","journal-title":"Br J Psychiatry"},{"key":"4148_CR4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.genhosppsych.2003.08.002","volume":"26","author":"Allen","year":"2004","unstructured":"Allen MH, Currier GW (2004) Use of restraints and pharmacotherapy in academic psychiatric emergency services. Gen Hosp Psychiatry 26:42\u201349","journal-title":"Gen Hosp Psychiatry"},{"key":"4148_CR5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/YIC.0000000000000064","volume":"30","author":"Asadollahi","year":"2015","unstructured":"Asadollahi S, Heidari K, Hatamabadi H et al (2015) Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial. Int Clin Psychopharmacol 30:142\u2013150","journal-title":"Int Clin Psychopharmacol"},{"key":"4148_CR6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1176\/appi.psy.48.6.534","volume":"48","author":"Babington","year":"2007","unstructured":"Babington PW, Spiegel DR (2007) Treatment of catatonia with olanzapine and amantadine. Psychosomatics 48:534\u2013536","journal-title":"Psychosomatics"},{"key":"4148_CR7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1590\/S1516-44462011000100008","volume":"33","author":"Baldacara","year":"2011","unstructured":"Baldacara L, Sanches M, Cordeiro DC, Jackoswski AP (2011) Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone. Rev Bras Psiquiatr 33:30\u201339","journal-title":"Rev Bras Psiquiatr"},{"key":"4148_CR8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/01.JGP.0000216325.42721.99","volume":"14","author":"Barak","year":"2006","unstructured":"Barak Y, Mazeh D, Plopski I, Baruch Y (2006) Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia. Am J Geriatr Psychiatry 14:629\u2013633","journal-title":"Am J Geriatr Psychiatry"},{"key":"4148_CR9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1176\/ajp.149.4.506","volume":"149","author":"Barbee","year":"1992","unstructured":"Barbee JG, Mancuso DM, Freed CR, Todorov AA (1992) Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia. Am J Psychiatry 149:506\u2013510","journal-title":"Am J Psychiatry"},{"key":"4148_CR10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00019442-200303000-00014","volume":"11","author":"Bartels","year":"2003","unstructured":"Bartels SJ, Horn SD, Smout RJ et al (2003) Agitation and depression in frail nursing home elderly patients with dementia: treatment characteristics and service use. Am J Geriatr Psychiatry 11:231\u2013238","journal-title":"Am J Geriatr Psychiatry"},{"key":"4148_CR11","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2165\/00003495-200565090-00003","volume":"65","author":"Battaglia","year":"2005","unstructured":"Battaglia J (2005) Pharmacological management of acute agitation. Drugs 65:1207\u20131222","journal-title":"Drugs"},{"key":"4148_CR12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0735-6757(97)90119-4","volume":"15","author":"Battaglia","year":"1997","unstructured":"Battaglia J, Moss S, Rush J et al (1997) Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med 15:335\u2013340","journal-title":"Am J Emerg Med"},{"key":"4148_CR13","first-page":"CD003729","volume":"Rev","author":"Belgamwar","year":"2005","unstructured":"Belgamwar RB, Fenton M (2005) Olanzapine IM or velotab for acutely disturbed\/agitated people with suspected serious mental illnesses. Cochrane Database Syst Rev:CD003729","journal-title":"Cochrane Database Syst"},{"key":"4148_CR14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40268-014-0078-0","volume":"15","author":"Belvederi","year":"2015","unstructured":"Belvederi Murri M, Guaglianone A, Bugliani M et al (2015) Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis. Drugs R D 15:45\u201362","journal-title":"Drugs R D"},{"key":"4148_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/j.1875-9114.1998.tb03827.x","volume":"18","author":"Bieniek","year":"1998","unstructured":"Bieniek SA, Ownby RL, Penalver A, Dominguez RA (1998) A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy 18:57\u201362","journal-title":"Pharmacotherapy"},{"key":"4148_CR16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archpsyc.59.5.441","volume":"59","author":"Breier","year":"2002","unstructured":"Breier A, Meehan K, Birkett M et al (2002) A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry 59:441\u2013448","journal-title":"Arch Gen Psychiatry"},{"key":"4148_CR17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1176\/jnp.2007.19.4.406","volume":"19","author":"Carroll","year":"2007","unstructured":"Carroll BT, Goforth HW, Thomas C et al (2007) Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes. J Neuropsychiatry Clin Neurosci 19:406\u2013412","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"4148_CR18","doi-asserted-by":"crossref","unstructured":"Cavallazzi R, Saad M, Marik PE (2012) Delirium in the ICU: an overview: Ann Intensive Care 2:49","DOI":"10.1186\/2110-5820-2-49"},{"key":"4148_CR19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.annemergmed.2012.07.118","volume":"61","author":"Chan","year":"2013","unstructured":"Chan EW, Taylor DM, Knott JC et al (2013) Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Ann Emerg Med 61:72\u201381","journal-title":"Ann Emerg Med"},{"key":"4148_CR20","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.4088\/JCP.v68n1207","volume":"68","author":"Citrome","year":"2007","unstructured":"Citrome L (2007) Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. J Clin Psychiatry 68:1876\u20131885","journal-title":"J Clin Psychiatry"},{"key":"4148_CR21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1742-1241.2011.02890.x","volume":"66","author":"Citrome","year":"2012","unstructured":"Citrome L (2012) Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder. Int J Clin Pract 66:318\u2013325","journal-title":"Int J Clin Pract"},{"key":"4148_CR22","doi-asserted-by":"crossref","first-page":"638","DOI":"10.4088\/JCP.v67n0415","volume":"67","author":"Citrome","year":"2006","unstructured":"Citrome L, Volavka J, Czobor P et al (2006) Efficacy of ziprasidone against hostility in schizophrenia: post hoc analysis of randomized, open-label study data. J Clin Psychiatry 67:638\u2013642","journal-title":"J Clin Psychiatry"},{"key":"4148_CR23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11126-005-2977-2","volume":"76","author":"Crowner","year":"2005","unstructured":"Crowner ML, Peric G, Stepcic F, Lee S (2005) Assailant and victim behaviors immediately preceding inpatient assault. Psychiatr Q 76:243\u2013256","journal-title":"Psychiatr Q"},{"key":"4148_CR24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4088\/JCP.v65n0315","volume":"65","author":"Currier","year":"2004","unstructured":"Currier GW, Chou JC, Feifel D et al (2004) Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. J Clin Psychiatry 65:386\u2013394","journal-title":"J Clin Psychiatry"},{"key":"4148_CR25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eurpsy.2004.05.006","volume":"19","author":"De","year":"2004","unstructured":"De Fruyt J, Demyttenaere K (2004) Rapid tranquilization: new approaches in the emergency treatment of behavioral disturbances. Eur Psychiatry 19:243\u2013249","journal-title":"Eur Psychiatry"},{"key":"4148_CR26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/clc.4960180512","volume":"18","author":"Di","year":"1995","unstructured":"Di Salvo TG, O\u2019Gara PT (1995) Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients. Clin Cardiol 18:285\u2013290","journal-title":"Clin Cardiol"},{"key":"4148_CR27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1176\/ajp.156.1.142","volume":"156","author":"Dorevitch","year":"1999","unstructured":"Dorevitch A, Katz N, Zemishlany Z et al (1999) Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior. Am J Psychiatry 156:142\u2013144","journal-title":"Am J Psychiatry"},{"key":"4148_CR28","doi-asserted-by":"crossref","unstructured":"Dosi R, Ambaliya A, Joshi H, Patell R (2014) Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary. BMJ Case Rep 2014","DOI":"10.1136\/bcr-2014-204154"},{"key":"4148_CR29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00004850-199705000-00009","volume":"12","author":"Foster","year":"1997","unstructured":"Foster S, Kessel J, Berman ME, Simpson GM (1997) Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting. Int Clin Psychopharmacol 12:175\u2013179","journal-title":"Int Clin Psychopharmacol"},{"key":"4148_CR30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s13311-013-0240-3","volume":"11","author":"Frucht","year":"2014","unstructured":"Frucht SJ (2014) Treatment of movement disorder emergencies. Neurotherapeutics 11:208\u2013212","journal-title":"Neurotherapeutics"},{"key":"4148_CR31","doi-asserted-by":"crossref","unstructured":"Garza-Trevino ES, Hollister LE, Overall JE, Alexander WF (1989) Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation: Am J Psychiatry 146:1598\u20131601","DOI":"10.1176\/ajp.146.12.1598"},{"key":"4148_CR32","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/mds.23220","volume":"25","author":"Gillman","year":"2010","unstructured":"Gillman PK (2010) Neuroleptic malignant syndrome: mechanisms, interactions, and causality. Mov Disord 25:1780\u20131790","journal-title":"Mov Disord"},{"key":"4148_CR33","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v67n0702","volume":"67","author":"Goedhard","year":"2006","unstructured":"Goedhard LE, Stolker JJ, Heerdink ER et al (2006) Pharmacotherapy for the treatment of aggressive behavior in general adult psychiatry: a systematic review. J Clin Psychiatry 67:1013\u20131024","journal-title":"J Clin Psychiatry"},{"key":"4148_CR34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1345\/aph.1L371","volume":"43","author":"Gortney","year":"2009","unstructured":"Gortney JS, Fagan A, Kissack JC (2009) Neuroleptic malignant syndrome secondary to quetiapine. Ann Pharmacother 43:785\u2013791","journal-title":"Ann Pharmacother"},{"key":"4148_CR35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jpsychores.2011.01.019","volume":"71","author":"Grover","year":"2011","unstructured":"Grover S, Kumar V, Chakrabarti S (2011) Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium. J Psychosom Res 71:277\u2013281","journal-title":"J Psychosom Res"},{"key":"4148_CR36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0033-3182(04)70170-X","volume":"45","author":"Han","year":"2004","unstructured":"Han CS, Kim YK (2004) A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 45:297\u2013301","journal-title":"Psychosomatics"},{"key":"4148_CR37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00004714-200106000-00002","volume":"21","author":"Hatta","year":"2001","unstructured":"Hatta K, Takahashi T, Nakamura H et al (2001) The association between intravenous haloperidol and prolonged QT interval. J Clin Psychopharmacol 21:257\u2013261","journal-title":"J Clin Psychopharmacol"},{"key":"4148_CR38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/0269881105048897","volume":"19","author":"Hovens","year":"2005","unstructured":"Hovens JE, Dries PJ, Melman CT et al (2005) Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study. J Psychopharmacol 19:51\u201357","journal-title":"J Psychopharmacol"},{"key":"4148_CR39","first-page":"CD003499","volume":"Rev","author":"Huband","year":"2010","unstructured":"Huband N, Ferriter M, Nathan R, Jones H (2010) Antiepileptics for aggression and associated impulsivity. Cochrane Database Syst Rev:CD003499","journal-title":"Cochrane Database Syst"},{"key":"4148_CR40","first-page":"CD005146","volume":"Rev","author":"Huf","year":"2009","unstructured":"Huf G, Alexander J, Allen MH, Raveendran NS (2009) Haloperidol plus promethazine for psychosis-induced aggression. Cochrane Database Syst Rev:CD005146","journal-title":"Cochrane Database Syst"},{"key":"4148_CR41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1192\/bjp.bp.110.083030","volume":"198","author":"Jones","year":"2011","unstructured":"Jones RM, Arlidge J, Gillham R et al (2011) Efficacy of mood stabilisers in the treatment of impulsive or repetitive aggression: systematic review and meta-analysis. Br J Psychiatry 198:93\u201398","journal-title":"Br J Psychiatry"},{"key":"4148_CR42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/hup.1117","volume":"25","author":"Kim","year":"2010","unstructured":"Kim SW, Yoo JA, Lee SY et al (2010) Risperidone versus olanzapine for the treatment of delirium. Hum Psychopharmacol 25:298\u2013302","journal-title":"Hum Psychopharmacol"},{"key":"4148_CR43","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/JCP.0b013e31818aaf6c","volume":"28","author":"Kinon","year":"2008","unstructured":"Kinon BJ, Stauffer VL, Kollack-Walker S et al (2008) Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia. J Clin Psychopharmacol 28:601\u2013607","journal-title":"J Clin Psychopharmacol"},{"key":"4148_CR44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3371\/CSRP.4.3.5","volume":"4","author":"Kirino","year":"2010","unstructured":"Kirino E (2010) Prolonged catatonic stupor successfully treated with aripiprazole in an adolescent male with schizophrenia: a case report. Clin Schizophr Relat Psychoses 4:185\u2013188","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"4148_CR45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annemergmed.2005.07.003","volume":"47","author":"Knott","year":"2006","unstructured":"Knott JC, Taylor DM, Castle DJ (2006) Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department. Ann Emerg Med 47:61\u201367","journal-title":"Ann Emerg Med"},{"key":"4148_CR46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-2005-915330","volume":"34","author":"Kropp","year":"2007","unstructured":"Kropp S, Andreis C, te Wildt B et al (2007) Characteristics of psychiatric patients in the accident and emergency department (ED). Psychiatr Prax 34:72\u201375","journal-title":"Psychiatr Prax"},{"key":"4148_CR47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1399-5618.2011.00975.x","volume":"14","author":"Kwentus","year":"2012","unstructured":"Kwentus J, Riesenberg RA, Marandi M et al (2012) Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine. Bipolar Disord 14:31\u201340","journal-title":"Bipolar Disord"},{"key":"4148_CR48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00004850-200511000-00005","volume":"20","author":"Lee","year":"2005","unstructured":"Lee KU, Won WY, Lee HK et al (2005) Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study. Int Clin Psychopharmacol 20:311\u2013314","journal-title":"Int Clin Psychopharmacol"},{"key":"4148_CR49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1192\/bjp.bp.110.081513","volume":"198","author":"Lesem","year":"2011","unstructured":"Lesem MD, Tran-Johnson TK, Riesenberg RA et al (2011) Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. Br J Psychiatry 198:51\u201358","journal-title":"Br J Psychiatry"},{"key":"4148_CR50","first-page":"CD005594","volume":"Rev","author":"Lonergan","year":"2007","unstructured":"Lonergan E, Britton AM, Luxenberg J, Wyller T (2007) Antipsychotics for delirium. Cochrane Database Syst Rev:CD005594","journal-title":"Cochrane Database Syst"},{"key":"4148_CR51","first-page":"CD003945","volume":"Rev","author":"Lonergan","year":"2009","unstructured":"Lonergan E, Luxenberg J (2009) Valproate preparations for agitation in dementia. Cochrane Database Syst Rev:CD003945","journal-title":"Cochrane Database Syst"},{"key":"4148_CR52","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ajem.2005.02.050","volume":"23","author":"Marco","year":"2005","unstructured":"Marco CA, Vaughan J (2005) Emergency management of agitation in schizophrenia. Am J Emerg Med 23:767\u2013776","journal-title":"Am J Emerg Med"},{"key":"4148_CR53","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1590\/S0004-282X2011000600005","volume":"69","author":"Moscovich","year":"2011","unstructured":"Moscovich M, Novak FT, Fernandes AF et al (2011) Neuroleptic malignant syndrome. Arq Neuropsiquiatr 69:751\u2013755","journal-title":"Arq Neuropsiquiatr"},{"key":"4148_CR54","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1590\/S0004-282X2012000600013","volume":"70","author":"Munhoz","year":"2012","unstructured":"Munhoz RP, Moscovich M, Araujo PD, Teive HA (2012) Movement disorders emergencies: a review. Arq Neuropsiquiatr 70:453\u2013461","journal-title":"Arq Neuropsiquiatr"},{"key":"4148_CR55","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12024-013-9410-1","volume":"9","author":"Musshoff","year":"2013","unstructured":"Musshoff F, Doberentz E, Madea B (2013) Lethal neuroleptic malignant syndrome due to amisulpride. Forensic Sci Med Pathol 9:218\u2013220","journal-title":"Forensic Sci Med Pathol"},{"key":"4148_CR56","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1176\/ps.49.11.1452","volume":"49","author":"Owen","year":"1998","unstructured":"Owen C, Tarantello C, Jones M, Tennant C (1998) Violence and aggression in psychiatric units. Psychiatr Serv 49:1452\u20131457","journal-title":"Psychiatr Serv"},{"key":"4148_CR57","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.genhosppsych.2008.03.005","volume":"30","author":"Pajonk","year":"2008","unstructured":"Pajonk FG, Schmitt P, Biedler A et al (2008) Psychiatric emergencies in prehospital emergency medical systems: a prospective comparison of two urban settings. Gen Hosp Psychiatry 30:360\u2013366","journal-title":"Gen Hosp Psychiatry"},{"key":"4148_CR58","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-2006-941489","volume":"39","author":"Pascual","year":"2006","unstructured":"Pascual JC, Madre M, Soler J et al (2006b) Injectable atypical antipsychotics for agitation in borderline personality disorder. Pharmacopsychiatry 39:117\u2013118","journal-title":"Pharmacopsychiatry"},{"key":"4148_CR59","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/0253-7613.106448","volume":"45","author":"Patra","year":"2013","unstructured":"Patra BN, Khandelwal SK, Sood M (2013) Olanzapine induced neuroleptic malignant syndrome. Indian J Pharmacol 45:98\u201399","journal-title":"Indian J Pharmacol"},{"key":"4148_CR60","first-page":"109","volume":"7","author":"Pelland","year":"2009","unstructured":"Pelland C, Trudel JF (2009) Atypical antipsychotic efficacy and safety in managing delirium: a systematic review and critical analysis. Psychol Neuropsychiatr Vieil 7:109\u2013119","journal-title":"Psychol Neuropsychiatr Vieil"},{"key":"4148_CR61","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.schres.2009.12.023","volume":"118","author":"Peralta","year":"2010","unstructured":"Peralta V, Campos MS, Jalon EG de, Cuesta MJ (2010) DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication. Schizophr Res 118:168\u2013175","journal-title":"Schizophr Res"},{"key":"4148_CR62","first-page":"155","volume":"24","author":"Perry","year":"2012","unstructured":"Perry PJ, Wilborn CA (2012) Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Ann Clin Psychiatry 24:155\u2013162","journal-title":"Ann Clin Psychiatry"},{"key":"4148_CR63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1192\/bjp.165.1.107","volume":"165","author":"Powell","year":"1994","unstructured":"Powell G, Caan W, Crowe M (1994) What events precede violent incidents in psychiatric hospitals? Br J Psychiatry 165:107\u2013112","journal-title":"Br J Psychiatry"},{"key":"4148_CR64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/acps.12262","volume":"130","author":"Pratts","year":"2014","unstructured":"Pratts M, Citrome L, Grant W et al (2014) A single-dose, randomized, double-blind, placebo-controlled trial of sublingual asenapine for acute agitation. Acta Psychiatr Scand 130:61\u201368","journal-title":"Acta Psychiatr Scand"},{"key":"4148_CR65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00101-012-1991-7","volume":"61","author":"Puffer","year":"2012","unstructured":"Puffer E, Messer T, Pajonk FG (2012) Psychiatric care in emergency departments. Anaesthesist 61:215\u2013223","journal-title":"Anaesthesist"},{"key":"4148_CR66","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/bmj.39341.608519.BE","volume":"335","author":"Raveendran","year":"2007","unstructured":"Raveendran NS, Tharyan P, Alexander J, Adams CE (2007) Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. BMJ 335:865","journal-title":"BMJ"},{"key":"4148_CR67","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.pnpbp.2006.01.015","volume":"30","author":"Rocca","year":"2006","unstructured":"Rocca P, Villari V, Bogetto F (2006) Managing the aggressive and violent patient in the psychiatric emergency. Prog Neuropsychopharmacol Biol Psychiatry 30:586\u2013598","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4148_CR68","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00101-010-1812-9","volume":"60","author":"Rortgen","year":"2011","unstructured":"Rortgen D, Schaumberg A, Skorning M et al (2011) Stocked medications in emergency physician-based medical services in Germany. Reality and requirements according to guidelines. Anaesthesist 60:312\u2013324","journal-title":"Anaesthesist"},{"key":"4148_CR69","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.4088\/JCP.v69n1204","volume":"69","author":"Satterthwaite","year":"2008","unstructured":"Satterthwaite TD, Wolf DH, Rosenheck RA et al (2008) A meta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation. J Clin Psychiatry 69:1869\u20131879","journal-title":"J Clin Psychiatry"},{"key":"4148_CR70","doi-asserted-by":"crossref","unstructured":"Schwerth\u00f6ffer D, Beuys D, Hamann J et al (2015) Versorgung psychiatrischer Notf\u00e4lle in psychiatrischen Kliniken in Deutschland. Psychiatr Prax. DOI 10.1055\/s-0034-1387644","DOI":"10.1055\/s-0034-1387644"},{"key":"4148_CR71","first-page":"CD008191","volume":"Rev","author":"Seitz","year":"2011","unstructured":"Seitz DP, Adunuri N, Gill SS et al (2011) Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev:CD008191","journal-title":"Cochrane Database Syst"},{"key":"4148_CR72","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00134-003-2117-0","volume":"30","author":"Skrobik","year":"2004","unstructured":"Skrobik YK, Bergeron N, Dumont M, Gottfried SB (2004) Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 30:444\u2013449","journal-title":"Intensive Care Med"},{"key":"4148_CR73","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1176\/ajp.2007.164.6.870","volume":"164","author":"Strawn","year":"2007","unstructured":"Strawn JR, Keck PE Jr, Caroff SN (2007) Neuroleptic malignant syndrome. Am J Psychiatry 164:870\u2013876","journal-title":"Am J Psychiatry"},{"key":"4148_CR74","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1176\/ajp.139.6.847-b","volume":"139","author":"Tardiff","year":"1982","unstructured":"Tardiff K, Sweillam A (1982) Assaultive behavior among chronic inpatients. Am J Psychiatry 139:212\u2013215","journal-title":"Am J Psychiatry"},{"key":"4148_CR75","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1192\/bjp.bp.111.105189","volume":"201","author":"Trollor","year":"2012","unstructured":"Trollor JN, Chen X, Chitty K, Sachdev PS (2012) Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics. Br J Psychiatry 201:52\u201356","journal-title":"Br J Psychiatry"},{"key":"4148_CR76","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1080\/j.1440-1614.1999.00630.x","volume":"33","author":"Trollor","year":"1999","unstructured":"Trollor JN, Sachdev PS (1999) Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust N Z J Psychiatry 33:650\u2013659","journal-title":"Aust N Z J Psychiatry"},{"key":"4148_CR77","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.genhosppsych.2012.11.004","volume":"35","author":"Uguz","year":"2013","unstructured":"Uguz F, Sonmez EO (2013) Neuroleptic malignant syndrome following combination of sertraline and paroxetine: a case report. Gen Hosp Psychiatry 35:327","journal-title":"Gen Hosp Psychiatry"},{"key":"4148_CR78","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2165\/11318880-000000000-00000","volume":"26","author":"Vieweg","year":"2009","unstructured":"Vieweg WV, Wood MA, Fernandez A et al (2009) Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly. Drugs Aging 26:997\u20131012","journal-title":"Drugs Aging"},{"key":"4148_CR79","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.pnpbp.2007.09.007","volume":"32","author":"Villari","year":"2008","unstructured":"Villari V, Rocca P, Fonzo V et al (2008) Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation. Prog Neuropsychopharmacol Biol Psychiatry 32:405\u2013413","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4148_CR80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2165\/00023210-200519020-00005","volume":"19","author":"Wagstaff","year":"2005","unstructured":"Wagstaff AJ, Easton J, Scott LJ (2005) Intramuscular olanzapine: a review of its use in the management of acute agitation. CNS Drugs 19:147\u2013164","journal-title":"CNS Drugs"},{"key":"4148_CR81","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/pcn.12066","volume":"67","author":"Wang","year":"2013","unstructured":"Wang HR, Woo YS, Bahk WM (2013) Atypical antipsychotics in the treatment of delirium. Psychiatry Clin Neurosci 67:323\u2013331","journal-title":"Psychiatry Clin Neurosci"},{"key":"4148_CR82","first-page":"116","volume":"24","author":"Wang","year":"2012","unstructured":"Wang Y, He R, Zhang H (2012) Case report on clozapine-associated neuroleptic malignant syndrome. Shanghai Arch Psychiatry 24:116\u2013117","journal-title":"Shanghai Arch Psychiatry"},{"key":"4148_CR83","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jemermed.2011.01.024","volume":"43","author":"Wilson","year":"2012","unstructured":"Wilson MP, MacDonald K, Vilke GM, Feifel D (2012) A comparison of the safety of olanzapine and haloperidol in combination with benzodiazepines in emergency department patients with acute agitation. J Emerg Med 43:790\u2013797","journal-title":"J Emerg Med"},{"key":"4148_CR84","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jemermed.2014.01.017","volume":"46","author":"Wilson","year":"2014","unstructured":"Wilson MP, Minassian A, Bahramzi M et al (2014) Despite expert recommendations, second-generation antipsychotics are not often prescribed in the emergency department. J Emerg Med 46:808\u2013813","journal-title":"J Emerg Med"},{"key":"4148_CR85","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5811\/westjem.2011.9.6866","volume":"13","author":"Wilson","year":"2012","unstructured":"Wilson MP, Pepper D, Currier GW et al (2012) The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup. West J Emerg Med 13:26\u201334","journal-title":"West J Emerg Med"},{"key":"4148_CR86","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.158.7.1149","volume":"158","author":"Wright","year":"2001","unstructured":"Wright P, Birkett M, David SR et al (2001) Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry 158:1149\u20131151","journal-title":"Am J Psychiatry"},{"key":"4148_CR87","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.clinthera.2010.03.006","volume":"32","author":"Zeller","year":"2010","unstructured":"Zeller SL, Rhoades RW (2010) Systematic reviews of assessment measures and pharmacologic treatments for agitation. Clin Ther 32:403\u2013425","journal-title":"Clin Ther"},{"key":"4148_CR88","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1176\/appi.ajp.2009.09050703","volume":"167","author":"Zisselman","year":"2010","unstructured":"Zisselman MH, Jaffe RL (2010) ECT in the treatment of a patient with catatonia: consent and complications. Am J Psychiatry 167:127\u2013132","journal-title":"Am J Psychiatry"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-014-4148-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-014-4148-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-014-4148-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T09:02:30Z","timestamp":1652864550000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-014-4148-x"}},"subtitle":["Allgemeine Prinzipien"],"short-title":[],"issued":{"date-parts":[[2015,7,19]]},"references-count":88,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["4148"],"URL":"https:\/\/doi.org\/10.1007\/s00115-014-4148-x","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,19]]}}}